Cannabix Technologies Inc. (CSE:BLO)
0.3900
0.00 (0.00%)
Sep 22, 2026, 3:45 PM EST
Cannabix Technologies Market Cap
Cannabix Technologies has a market cap or net worth of CAD 47.91 million as of September 22, 2026. Its market cap has decreased by -29.34% in one year.
Market Cap
47.91M
Enterprise Value
46.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
ChartMarket Cap Chart
Since December 18, 2013, Cannabix Technologies's market cap has increased from 574.76K to 47.91M, an increase of 8,235.37%. That is a compound annual growth rate of 41.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 47.91M | -31.78% |
| Dec 31, 2025 | 70.22M | 90.58% |
| Dec 31, 2024 | 36.85M | 79.34% |
| Dec 29, 2023 | 20.55M | -44.62% |
| Dec 30, 2022 | 37.10M | -39.81% |
| Dec 31, 2021 | 61.64M | -34.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 312.72M |
| Vector Science and Therapeutics | 295.53M |
| Theralase Technologies | 57.44M |
| Perimeter Medical Imaging AI | 44.50M |
| Cheelcare | 34.09M |
| Conavi Medical | 21.39M |
| MedX Health | 18.04M |
| Ventripoint Diagnostics | 17.36M |